Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-12
2009-08-11
Carlson, Karen Cochrane (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07572769
ABSTRACT:
The invention relates to a flowable fibrin adhesive granulate containing thrombin, Factor XIII, fibrinogen, and a calcium salt in the form of granules with a particle size of more than 50 μm to 1000 μm. Said granulate is useful for the healing of wounds in surgery, tissue therapy and/or as supporting material for biological factors. The invention also relates to an effervescent granulate and an effervescent powder for producing a foam that is suitable for hemostasis. The invention further relates to preparations to arrest bleeding containing a non-woven fabric for wounds consisting of a biodegradable supporting material that is coated with a fibrin glue granulate mixture or mixed granulate.
REFERENCES:
patent: 4427651 (1984-01-01), Stroetmann
patent: 4453939 (1984-06-01), Zimmerman et al.
patent: 6596318 (2003-07-01), Prasch et al.
patent: 2002/0037323 (2002-03-01), Prasch et al.
patent: 2003/0143518 (2003-07-01), Luck et al.
patent: 44 41 167 (1996-03-01), None
patent: A-100 12 732 (2001-09-01), None
patent: 0 792 188 (1994-09-01), None
patent: WO 92/22312 (1992-12-01), None
patent: WO 96/22115 (1996-07-01), None
patent: WO 96/29990 (1996-10-01), None
patent: WO 97/28832 (1997-08-01), None
patent: WO 97/44015 (1997-11-01), None
patent: WO 99/15637 (1999-04-01), None
Abstract of EP 0 792 188 dated Sep. 3, 1997, from Esp@cenet Database.
English-language translation of DE 44 41 167 C1 (Mar. 14, 1990).
English-language translation of German Patent Application No. DE-A-10012732 (Sep. 20, 2001).
Decision dated Dec. 18, 2002, from the German Patent Office in case No. 198 49 589.7-45.
Chabbat, J., et al., “Properties of a new fibrin glue stable in liquid state,” Thrombosis Research, 76(6):525-533 (1994).
De laco, PierAndrea, et al., “Fibrin sealant in laparoscopic adhesion prevention in the rabbit uterine horn model,” Fertility and Sterility, 62(2):400-404 (1994).
Evrard, V.A.C., et al., “Peritoneal healing after fibrin glue application: a comparative study in a rat model,” Human Reproduction, 11(9):1877-1880 (1996).
Gauwerky, J.F.H., et al., “The effect of fibrin glue and peritoneal grafts in the prevention of intraperitonael adhesions,” Arch. Gynecol. Obstet., 247:161-166 (1990).
Lindenberg, S., et al., “Prevention of peritoneal adhesion formation by fibrin sealant,” Annales Chirurgiae et Gynaecologiae, 73:11-13 (1984).
Moro, Hisanaga, et al., “The effect of fibrin glue on inhibition of pericardial adhesions,” The Japanese Journal of Thoracic and Cardiovascular Surgery, 47(2):79-84 (1999).
Takeuchi, Hiroyuki, et al., “Effects of fibrin glue on postsurgical adhesions after uterine or ovarian surgery in rabbits,” J. Obstet. Gynaecol. Res., 23(5):479-484 (1997).
Voight, Rudolf, et al., “Lehrbuch der pharmazeutischen technologie,” 85 0570 EPO; Verla chemie (1984).
English-language translation of Voight, Rudolf, et al., “Lehrbuch der pharmazeutischen technologie,” 85 0570 EPO; Verla chemie (1984).
Prunkard, D., et al., “Heterologous production of recominant human fibrinogen, thrombin, and factor XIII as components of completely recombinant fibrin sealants,” Thrombosis and Haemostasis 9:372 (1997).
Schuefer, Torben, et al., “Control of fluidized bed granulation v. factors affecting granule growth,” Arch. Pharm. Chemi, Sci. Ed., 6:68-82 (1978).
International Search Report for PCT/EP99/06898 (WO 00/38752) dated Dec. 21, 1999.
International Search Report for PCT/EP00/08128 (WO 00/024436) dated Jan. 25, 2000.
Luy Bernhard
Prasch Armin
Rapp Mirna
Carlson Karen Cochrane
CSL Behring GmbH
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Glatt Process Technology GmbH
LandOfFree
Fibrin adhesive granulate and method for its preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrin adhesive granulate and method for its preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrin adhesive granulate and method for its preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4074872